Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 6, Number 5—October 2000

Research

Atypical Chryseobacterium meningosepticum and Meningitis and Sepsis in Newborns and the Immunocompromised, Taiwan

Cheng-Hsun Chiu*Comments to Author , Michael Waddingdon†, Wu-Shiun Hsieh*, David Greenberg‡, Paul C. Schreckenberger§, and Amy M. Carnahan¶
Author affiliations: *Chang Gung Children's Hospital, Taoyuan, Taiwan; †Accugenix, Inc., Newark, Delaware; ‡British Columbia's Children's Hospital, Vancouver, British Columbia, Canada; §University of Illinois at Chicago Medical Center, Chicago, Illinois, USA; ¶University of Maryland School of Medicine, Baltimore, Maryland, USA

Main Article

Table 2

Comparative in vitro activity of various antibiotics against 17 strains of atypical Chryseobacterium meningosepticum

MIC (µg/mL)
Antibiotics Range MIC50 MIC90
Ampicillin 16-64 32 32
Ticarcillin 32->128 128 >128
Piperacillin 1-128 8 32
Cephalothin 32->32 32 32
Cefamandole 16->32 >32 >32
Cefotaxime 8->32 32 >32
Ceftriaxone 8->32 16 32
Imipenem 1->32 32 32
Ceftazidime 2-64 16 >32
Gentamicin 16-64 32 64
Amikacin 2-64 64 64
Ciprofloxacin 0.25-16 1 4

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO